SSY Group Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares SSY Group Ltd with three other
companies in this sector in China:
Zhejiang Xianju Pharmaceutical Co Limited
sales of 3.62 billion Chinese Renmimbi [US$518.06 million]
of which 100%
Haisco Pharmaceutical Group Co Ltd
(3.43 billion Chinese Renmimbi [US$490.15 million]
of which 71%
was Parent company), and
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(3.33 billion Chinese Renmimbi [US$476.07 million]
of which 49%
was Medicine Manufacturing).
SSY Group Ltd reported sales of 3.53 billion Chinese Renmimbi (US$505.17 million)
December of 2018.
increase of 32.9%
versus 2017, when the company's sales were 2.66 billion Chinese Renmimbi.
This was the fourth straight year of sales growth at SSY Group Ltd.
Sales of Intravenous Infusion Solution and Others saw an increase
33.7% in 2018, from
2.54 billion Chinese Renmimbi to 3.40 billion Chinese Renmimbi.